Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bridging the Neurocomputational Explanations of Paranoia: From Cognition to Clinic
NCT07878130Phase 2Not yet recruiting
- Sponsor
- King's College London
- Start
- Nov 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol, sponsored by King's College London. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
dronabinol
Beyond the preview
Go deeper on NCT07878130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07878130.